Pro Share Advisors LLC Replimune Group, Inc. Transaction History

Pro Share Advisors LLC

$46.4 Billion
Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 14,611 shares of REPL stock, worth $131,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,611

Previous 16,383 10.82%

Holding current value

$131,352

Previous $152,000 59.87%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$2.81 - $12.63 $4,979 - $22,380	-1,772 Reduced 10.82%	14,611 $61,000
Q2 2025 Aug 07, 2025	SELL	$6.92 - $10.38 $13,355 - $20,033	-1,930 Reduced 10.54%	16,383 $152,000
Q1 2025 May 08, 2025	SELL	$9.75 - $14.31 $24,131 - $35,417	-2,475 Reduced 11.91%	18,313 $178,000
Q4 2024 Feb 13, 2025	BUY	$10.54 - $14.93 $55,303 - $78,337	5,247 Added 33.76%	20,788 $251,000
Q3 2024 Nov 13, 2024	BUY	$8.09 - $11.23 $41,477 - $57,576	5,127 Added 49.23%	15,541 $170,000

Q2 2024 Aug 13, 2024	SELL	$5.01 - $9.46 $13,887 - $26,223	-2,772 Reduced 21.02%	10,414 $93,000
Q1 2024 May 08, 2024	BUY	$6.87 - $9.31 $8,429 - $11,423	1,227 Added 10.26%	13,186 $107,000
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $80,723 - $193,496	11,959 New	11,959 $100,000
Q2 2023 Aug 10, 2023	BUY	$15.65 - $24.1 $141,429 - $217,791	9,037 New	9,037 $209,000
Q4 2022 Feb 02, 2023	BUY	$17.09 - $27.91 $159,637 - $260,707	9,341 New	9,341 $254,000
Q2 2022 Aug 01, 2022	SELL	$13.32 - $19.98 $140,499 - $210,749	-10,548 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$15.24 - $29.75 $38,831 - $75,803	-2,548 Reduced 19.46%	10,548 $179,000
Q4 2021 Feb 08, 2022	SELL	$25.43 - $34.25 $18,055 - $24,317	-710 Reduced 5.14%	13,096 $355,000
Q3 2021 Nov 12, 2021	SELL	$28.98 - $39.54 $43,875 - $59,863	-1,514 Reduced 9.88%	13,806 $409,000
Q2 2021 Aug 13, 2021	BUY	$28.5 - $39.37 $70,081 - $96,810	2,459 Added 19.12%	15,320 $589,000
Q1 2021 May 14, 2021	BUY	$30.22 - $45.57 $15,170 - $22,876	502 Added 4.06%	12,861 $392,000
Q4 2020 Feb 09, 2021	BUY	$23.5 - $52.65 $290,436 - $650,701	12,359 New	12,359 $471,000
Q3 2019 Nov 12, 2019	SELL	$10.01 - $16.87 $104,844 - $176,696	-10,474 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$12.51 - $17.28 $19,403 - $26,801	-1,551 Reduced 12.9%	10,474 $154,000
Q1 2019 May 15, 2019	BUY	$10.26 - $16.24 $5,571 - $8,818	543 Added 4.73%	12,025 $183,000
Q4 2018 Feb 14, 2019	BUY	$9.97 - $15.57 $114,475 - $178,774	11,482 New	11,482 $115,000

Others Institutions Holding REPL

# of Institutions

192

Shares Held

80.4M

Call Options Held

8.69M

Put Options Held

2.28M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $443M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Replimune Group, Inc. Transaction History